3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with pitavastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igel, M; Sudhop, T; von Bergmann, K | 1 |
| Koike, Y; Kuwatsuka, S; Kuwatsuka, Y; Murota, H; Yamaoka, T | 1 |
1 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and pitavastatin
| Article | Year |
|---|---|
Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin.
Topics: Acyl Coenzyme A; Coronary Disease; Enzyme Inhibitors; Fluorobenzenes; Hypolipidemic Agents; Pyrimidines; Quinolines; Rosuvastatin Calcium; Sulfonamides | 2002 |
1 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and pitavastatin
| Article | Year |
|---|---|
Claudin-7 in keratinocytes is downregulated by the inhibition of HMG-CoA reductase and is highly expressed in the stratum granulosum of the psoriatic epidermis.
Topics: Acyl Coenzyme A; Claudins; Down-Regulation; Epidermis; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Microscopy, Immunoelectron; Psoriasis; Quinolines; Transcriptome | 2021 |